| 股票代码 | 600521 | 当期评分 | ||||
| 股票名称 | 华海药业 | |||||
| 报告日期 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | 0.4152 | 0.524 | 0.0543 | 1.3264 | 0.8032 | ✘ |
| 销售净利润率(%) | 11.1633 | 12.4668 | 2.6479 | 11.2623 | 18.212 | ✔ |
| 销售毛利率(%) | 48.862 | 54.7431 | 58.6015 | 59.4663 | 62.7355 | ✔ |
| 净资产收益率(%) | 11.43 | 13.09 | 2.64 | 10.15 | 13.6 | ✘ |
| 营业增长率(%) | 16.9266 | 22.2131 | 1.8511 | 5.761 | 21.4134 | ✔ |
| 净利润增长率(%) | 4.6204 | 36.4825 | -78.367 | 349.8299 | 63.4629 | ✔ |
| 每股收益(%) | 0.49 | 0.62 | 0.09 | 0.45 | 0.58 | ✔ |
| 现金流量比率(%) | 28.6112 | 19.2672 | 1.4245 | 52.2476 | 29.155 | ✔ |
| 三项费用比重(%) | 35.8239 | 40.2823 | 45.3001 | 37.7932 | 33.5602 | ✔ |
| 每股净资产(¥) | 4.2026 | 4.6832 | 3.2536 | 4.2421 | 4.2501 | ✔ |
| 流动比率(%) | 2.3197 | 1.4364 | 1.0936 | 1.5689 | 1.4285 | ✔ |
| 速动比率(%) | 1.4409 | 0.8742 | 0.6352 | 0.9085 | 0.8343 | ✘ |
| 现金比率(%) | 52.2934 | 24.3845 | 19.1096 | 44.8157 | 44.8157 | ✔ |
| 总资产利润率(%) | 7.4645 | 8.3183 | 1.4479 | 5.7528 | 7.8274 | ✔ |
| 主营利润比重% | 352.6656 | 351.3971 | 1898.6738 | 421.1137 | 285.8194 | ✔ |
| 应收账款(万元) | 128,091.65 | 160,422.90 | 189,434.97 | 128,911.44 | 163,383.21 | ✘ |
| 应收票据(万元) | 2,589.72 | 5,284.59 | 4,203.48 | -- | -- | ✘ |
| 预付款项(万元) | 3,570.47 | 7,640.92 | 5,882.29 | 4,616.11 | 6,836.89 | ✔ |
| 存货(万元) | 133,023.19 | 159,383.52 | 218,480.54 | 221,702.61 | 238,074.05 | ✘ |
| 在建工程(万元) | 69,587.99 | 70,491.27 | 81,181.00 | 92,985.29 | 129,934.15 | ✔ |
| 应付款项(万元) | 36,331.17 | 38,984.33 | 42,830.55 | 37,652.59 | 38,962.47 | ✘ |
| 长期借款(万元) | 53,468.50 | 22,216.29 | 90,000.00 | 117,919.32 | 113,380.91 | ✔ |
| 未分配利润(万元) | 182,130.02 | 220,980.99 | 209,159.09 | 259,119.07 | 316,725.05 | ✔ |
| 商誉(万元) | 7,090.22 | 7,090.22 | 7,090.22 | 7,090.22 | 7,090.22 | ✔ |
| 流动资产(万元) | 321,502.96 | 419,463.27 | 515,503.56 | 546,265.30 | 621,150.54 | ✔ |
| 流动负债(万元) | 151,374.26 | 283,508.90 | 476,626.14 | 335,698.93 | 400,710.66 | ✔ |
华海药业600521评分结果 | 72.73分 | 买入/增持 | ||||